Research Overview: Emeset-4 ODT
Emeset-4 ODT 4 mg represents an orally disintegrating tablet formulation containing ondansetron hydrochloride, a selective 5-hydroxytryptamine-3 (5-HT3) receptor antagonist manufactured by Cipla for in-vitro laboratory research applications. This pharmaceutical-grade compound enables researchers at Stroid UK Shop to investigate antiemetic mechanisms, serotonin receptor interactions, and neurotransmitter pathway modulation in controlled laboratory environments. The ODT formulation provides unique dissolution characteristics for pharmaceutical research studies examining rapid-release drug delivery systems and bioavailability profiles in laboratory settings.
Laboratory Applications
Research teams utilise this ondansetron formulation to examine 5-HT3 receptor binding dynamics, investigate antiemetic pathways in cell culture models, and analyse pharmaceutical dissolution profiles. The compound serves as a valuable reference standard for studies examining serotonin antagonist mechanisms, particularly in gastroenterology research and neuropharmacology investigations. Researchers studying drug formulation technologies benefit from examining the ODT delivery system characteristics. This product complements other research compounds available in our miscellaneous research collection, alongside specialised compounds like SARMs and peptides for comprehensive pharmaceutical research programmes.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Ondansetron Hydrochloride |
| Strength | 4 mg per tablet |
| Formulation | Orally Disintegrating Tablet |
| Manufacturer | Cipla Limited |
| CAS Number | 99614-02-5 |
| Storage Requirements | Room temperature, dry conditions |
| Intended Use | Laboratory research only |
Compliance Statement
This ondansetron hydrochloride formulation is intended exclusively for qualified laboratory research applications and in-vitro studies. Researchers must maintain appropriate laboratory protocols and documentation when studying this compound. The product is not intended for human consumption, therapeutic use, or any non-research applications. All research activities should comply with institutional guidelines and regulatory requirements governing pharmaceutical research compounds.
